Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro

Scandinavian Journal of Immunology

Volumn 66, Issue 2-3, 2007, Pages 287-296

  Vendrame, C M V ^a   Carvalho, M D T ^a   Rios, F J O ^a   Manuli, E R ^a   Petitto Assis, F ^a   Goto, H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) HYDROXYARGININE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL INFECTION; FEMALE; HOST PARASITE INTERACTION; IN VITRO STUDY; INNATE IMMUNITY; LEISHMANIA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PARASITE SURVIVAL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; STATISTICAL SIGNIFICANCE;

EID: 34447332875     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01950.x     Document Type: Article

References (40)

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004 27 : 305 18.
2. Cunningham AC. Parasitic adaptive mechanisms in infection by leishmania. Exp Mol Pathol 2002 72 : 132 41.
3. Barcinski MA, Schechtman D, Quintao LG et al. Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death. Infect Immun 1992 60 : 3523 7.
4. Scott CL, Roe L, Curtis J et al. Mice unresponsive to GM-CSF are unexpectedly resistant to cutaneous Leishmania major infection. Microb Infect 2000 2 : 1131 8.
5. Barral-Netto M, Barral A, Brownell CE et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992 257 : 545 8.
6. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995 16 : 3 34.
7. Nagaoka I, Trapnell BC, Crystal RG. Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937. J Clin Invest 1990 85 : 448 55.
8. Gomes CM, Goto H, Corbett CE, Gidlund M. Insulin-like growth factor-1 is a growth promoting factor for Leishmania promastigotes. Acta Trop 1997 64 : 225 8.
9. Gomes CM, Monteiro HP, Gidlund M, Corbett CE, Goto H. Insulin-like growth factor-I induces phosphorylation in Leishmania (Leishmania) mexicana promastigotes and amastigotes. J Eukaryot Microbiol 1998 45 : 352 5.
10. Goto H, Gomes CM, Corbett CE, Monteiro HP, Gidlund M. Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes. Proc Natl Acad Sci U S A 1998 95 : 13211 6.
11. Gomes CM, Goto H, Ribeiro da Matta VL, Laurenti MD, Gidlund M, Corbett CE. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis. Int J Exp Pathol 2000 81 : 249 55.
12. Green SJ, Meltzer MS, Hibbs JB Jr., Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an l-arginine-dependent killing mechanism. J Immunol 1990 144 : 278 83.
13. Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J Immunol 1990 144 : 4794 7.
14. Roberts SC, Tancer MJ, Polinsky MR, Gibson KM, Heby O, Ullman B. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J Biol Chem 2004 279 : 23668 78.
15. Iniesta V, Gomez-Nieto LC, Molano I et al. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002 24 : 113 8.
16. Kropf P, Fuentes JM, Fahnrich E et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J 2005 19 : 1000 2.
17. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000 12 : 64 76.
18. Diefenbach A, Schindler H, Donhauser N et al. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998 8 : 77 87.
19. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap Mol Genet Metab 2004 81 (Suppl. 1 S38 44.
20. Morris SM Jr., Kepka-Lenhart D, Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 1998 275 : E740 7.
21. Camargo EP, Coelho JA, Moraes G, Figueiredo EN. Trypanosoma spp., Leishmania spp. and Leptomonas spp.: enzymes of ornithine-arginine metabolism. Exp Parasitol 1978 46 : 141 4.
22. Iniesta V, Gomez-Nieto LC, Corraliza I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001 193 : 777 84.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
24. Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994 174 : 231 5.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982 126 : 131 8.
26. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 1980 38 : 161 70.
27. Vincendeau P, Gobert AP, Daulouede S, Moynet D, Mossalayi MD. Arginases in parasitic diseases. Trends Parasitol 2003 19 : 9 12.
28. Guevara-Aguirre J. Insulin-like growth factor I - an important intrauterine growth factor. N Engl J Med 1996 335 : 1389 91.
29. Kratz G, Lake M, Gidlund M. Insulin like growth factor-1 and -2 and their role in the re-epithelialisation of wounds; interactions with insulin like growth factor binding protein type 1. Scand J Plast Reconstr Surg Hand Surg 1994 28 : 107 12.
30. Iniesta V, Carcelen J, Molano I et al. Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun 2005 73 : 6085 90.
31. Bossinger J, Cooper TG. Molecular events associated with induction of arginase in Saccharomyces cerevisiae. J Bacteriol 1977 131 : 163 73.
32. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine. J Biol Chem 1991 266 : 6259 63.
33. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998 160 : 5347 54.
34. Mora AL, Torres-Gonzalez E, Rojas M et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 2006 35 : 466 73.
35. Gobert AP, Daulouede S, Lepoivre M et al. l-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun 2000 68 : 4653 7.
36. Warwick-Davies J, Lowrie DB, Cole PJ. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. J Immunol 1995 154 : 1909 18.
37. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001 2 : 907 16.
38. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993 178 : 605 13.
39. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998 336 (Pt 1 1 17.
40. Wanasen N, Macleod CL, Ellies LG, Soong L. l-Arginine and cationic amino acid transporter-2B regulate growth and survival of Leishmania amazonensis amastigotes in macrophages. Infect Immun 2007 75 : 2802 10.